Pharmacycle SRL
The score of Pharmacycle shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -15 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacycle's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 May 2026
- Year ended 31 Dec 2024filed on 21 Feb 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
Pharmacycle's financial analysis
- Solvency70.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacycle
Pharmacycle's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0696.815.336
- VAT number
- BE0696815336
- Peppol
- Registered · 0208:0696815336 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 May 2018
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 29 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacycle (SRL) has been based in Brussels since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,640 € and equity of 29,178 €; its revenue is not published. Its solvency stands at 70.8%, above the median of its sector (37.8%).
Companies similar to Pharmacycle
Companies in the same business, of comparable size and area, outside its group.
- InEssence Studio Retail sale of pharmaceutical products Auderghem · balance sheet 29,309 €
- Quantum Satis Retail sale of pharmaceutical products Zele · balance sheet 34,289 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- 9 Into C Retail sale of pharmaceutical products Dendermonde · balance sheet 43,215 €
- DEL Pharma Retail sale of pharmaceutical products Mons · balance sheet 36,943 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- Buma Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 57,247 €
- Kephas Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 57,577 €
Frequently asked questions about Pharmacycle
What is the revenue of Pharmacycle?
Pharmacycle files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacycle?
In Belgium, the VAT number is the company number prefixed with BE: BE0696815336 for Pharmacycle, if the company is VAT-registered. Its company number (CBE) is 0696.815.336.
Where is the registered office of Pharmacycle?
According to the CBE register, the registered office of Pharmacycle is in 1000 Brussels.
What is the equity of Pharmacycle?
At the close of the 2025 financial year, the equity of Pharmacycle amounts to 29,178 €, a solvency of 70.8% of total assets.
Who manages Pharmacycle?
The register lists 1 active mandates at Pharmacycle. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacycle
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →